Advertisement
Canada markets closed
  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • Bitcoin CAD

    88,566.24
    +1,288.60 (+1.48%)
     
  • CMC Crypto 200

    1,334.09
    +21.47 (+1.64%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     
  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Magna (MGA) Develops Transmission for Ferrari SF90 Stradale

Magna International Inc. MGA recently announced that, in collaboration with sports car-maker, Ferarri, it has developed an innovative, next-generation dual-clutch 8-speed transmission (DCT) for the Ferrari SF90 Stradale.

Magna’s DCT powertrain technology combines light-weight, fuel-efficient technologies with highly-advanced engineering and manufacturing processes, providing a route to energy-efficient, modern mobility.

Per Magna, the state-of-the-art DCT incorporates latest technologies, like the honeycomb housing structure, which is expected to reduce vehicles’ weight by roughly 10 kg and boost torque-to-weight performance. The DCT will also help cut CO2 emissions.

Further, the Ferrari SF90 Stradale transmission will improve efficiency, weight and packaging in additional vehicle segments through technology transfer, benefiting Magna’s full line of conventional and hybrid DCTs, over the long run.

ADVERTISEMENT

Meanwhile, Magna is also expanding its business through joint ventures and hub openings while divesting the non-core units. In first-half 2019, the company inked a framework agreement for an electric vehicle manufacturing joint venture with an affiliate of BAIC. This August, it marked the opening of a $50-million electronics manufacturing facility in Michigan, which is expected to solidify its presence in Grand Blanc Township. Further, Magna is set to acquire Wipac Czech s.r.o., in a bid to expand its engineering capabilities globally.

In the past three months, shares of Magna have underperformed the industry it belongs to. Its shares have gained 3.4% compared with the industry’s rise of 5.5%.

For 2019, Magna projects consolidated revenues of $38.7-$39.8 billion, down from the previously estimated $38.9-$41.1 billion. The company anticipates adjusted EBIT margin of 6.3-6.5%, reflecting a decline from the prior guidance of 6.6-6.9%. Its free cash flow is estimated in the $1.9-2.1 billion band despite the reduction of the consolidated sales and margins projections for 2019.

Zacks Rank and Stocks to Consider

Currently, Magna carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the Auto-Tires-Trucks sector include Weichai Power Co. WEICY, Spartan Motors, Inc. SPAR and SPX Corporation SPXC. While Weichai Power flaunts a Zacks Rank #1 (Strong Buy), Spartan Motors and SPX carry a Zacks Rank of 2 (Buy), at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Weichai Power has a projected earnings growth rate of 6.11% for the current year. Its shares have gained 75.7% over the past year.

Spartan Motors has an estimated earnings growth rate of 85.42% for the ongoing year. The company’s shares have surged 157.2% in a year’s time.

SPX has an expected earnings growth rate of 23.18% for 2019. The stock has appreciated 92.3% in the past year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Magna International Inc. (MGA) : Free Stock Analysis Report
 
Spartan Motors, Inc. (SPAR) : Free Stock Analysis Report
 
SPX Corporation (SPXC) : Free Stock Analysis Report
 
Weichai Power Co. (WEICY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research